187
Participants
Start Date
May 22, 2014
Primary Completion Date
April 16, 2021
Study Completion Date
April 16, 2021
TheraSphere
TheraSphere® is delivered into the liver tumor through a catheter placed into the hepatic artery. The hepatic artery provides the main blood supply to the tumor in the liver, whereas the portal vein supplies blood to normal liver parenchyma. TheraSphere® is embolized within the tumor and exerts a local beta radiation radiotherapeutic effect with a relatively limited concurrent injury to surrounding normal tissue.
The Liver Institute at Methodist Dallas Medical Center, Dallas
Methodist Health System
OTHER